Hemispheric Hypoperfusion in Immune Effector Cell-Associated Neurotoxicity Syndrome following Chimeric Antigen Receptor T-Cell Therapy

Ann Neurol. 2024 Mar;95(3):617-619. doi: 10.1002/ana.26832. Epub 2023 Nov 29.

Authors

Nicolas Lambert¹, Julien Ly¹, Louis Deprez², Evelyne Willems³

Affiliations

¹ Department of Neurology, University Hospital of Liège, Liège, Belgium.
² Department of Radiology, University Hospital of Liège, Liège, Belgium.
³ Department of Hematology, University Hospital of Liège, Liège, Belgium.

PMID: 37975425
DOI: 10.1002/ana.26832

No abstract available

MeSH terms

Cell- and Tissue-Based Therapy
Humans
Immunotherapy, Adoptive / adverse effects
Neurotoxicity Syndromes* / etiology
Receptors, Chimeric Antigen*

Substances

cell-associated neurotoxicity
Receptors, Chimeric Antigen